跳至主要内容
临床试验/CTRI/2024/04/065569
CTRI/2024/04/065569尚未招募Unknown

Evaluation of in vivo safety and efficacy of hair care formulation in terms of hair growth effect. - NI

KAYA LIMITED0 个研究点目标入组 0 人开始时间: 待定最近更新:

试验速览

阶段
Unknown
状态
尚未招募
发起方

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

入选标准

  • Indian / Asian male & female subjects.
  • Healthy subjects (no infectious and evolutive pathology which could make the subject
  • vulnerable and stop the study, no pathology which could interfere with the study, no symptom
  • in the process of an exploratory checkup)
  • Between 30 and 50 years of age.
  • Skin is healthy on the studied anatomic unit (free of eczema, wounds, inflammatory scar….)
  • Having androgenetic alopecia of class I-2 to I-4 according to Ludwig Scale for females and
  • class II to III (including III, IIIA and IIIvertex) according to Norwood Hamilton Scale for males.

排除标准

  • For Females: Being pregnant or breastfeeding or having stopped to breastfeed in the past three
  • Having refused to give his/her assent by not signing the consent form
  • Taking part in another study liable to interfere with this study
  • Having a chronic dermatosis liable to modify the cutaneous reactivity on the tested area
  • Being insulin-dependent diabetic or non insulin-dependent diabetic with a recent therapy (less
  • than 6 months)
  • Having a progressive asthma (either under treatment or last fit in the last 2 years)
  • Being epileptic
  • Having non stabilized thyroid problems (requirement of a stabilized treatment for at least 6
  • Having cutaneous hypersensitivity
  • Having a diagnosed or highly probable allergy to one or several compounds of the cosmetic products
  • Following a chronic or intermittent medicinal treatment comprising any of the following
  • products: aspirin-based products, anti-inflammatories, antihistamines, anti-coagulants,
  • corticotherapy, taken by general or local routes (the only medication permitted is paracetamol)
  • Having undergone a surgery requiring a general anaesthetic of more than one hour in the past 6 months
  • Having changed his/ her cosmetic habits except those required by the protocol in the 14 days preceding the start of the study on the studied anatomic unit
  • Having applied a cosmetic product on the studied areas the first day of the study.
  • Refusing to follow the restrictions below during the study:
  • - For female, do not take part in any family planning activities leading to pregnancy and
  • breastfeeding.
  • - Do not take part in another study liable to interfere with this study
  • - Do not take medicinal treatment comprising any of the following products: aspirin-based products, anti-inflammatories, antihistamines, anti-coagulants, corticotherapy, taken by general or local routes (the only medication permitted is paracetamol).
  • - Do not change his cosmetic habits apart from the particular conditions mentioned in the protocol, on the studied anatomic unit.
  • - During the study: Do not use other hair care products than the tested products to the studied areas (Only provided test product is allowed).
  • - The day of the measurements: Hair must be washed with provided neutral shampoo. No other hair care product must be used.
  • Having naturally fair or white hair
  • Having a dermatosis on the scalp
  • Having history of any hormonal problem.
  • Having surgery history on the scalp (micro transplants …)
  • Refusing the shaving of an area of the scalp of about 1.5 cm², the first day of the study and several times during the study
  • Having presented a factor inducing a telogen effluvium in the 3 months preceding the start of the study (important stress, high fever…)
  • Presenting an acute or chronic general disease or pathology which could have an influence on hair endocrinopathy (diabetes, thyroid…), high blood pressure, renal problems, hepatic problems, known anemia.
  • Having contact allergy or atopic predisposition.
  • Having history of medical/surgical events that may significantly affect the study outcome e.g.,h/o typhoid or jaundice etc.

研究者

发起方
KAYA LIMITED

相似试验